Lung injury and bronchopulmonary dysplasia in newborn infants

Helen Christou1, Dara Brodsky

  • 1Division of Newborn Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA. helen.christou@childrens.harvard.edu

Insights

Bronchopulmonary dysplasia (BPD) is a common lung disease in premature infants. Further research into genetic factors, pathogenetic pathways, and clinical translation is needed to reduce BPD incidence and severity.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Developmental Biology

Background:

  • Bronchopulmonary dysplasia (BPD) is the most frequent complication in premature infants.
  • Lung injury in BPD arises from interactions between infant susceptibility and factors like mechanical ventilation and infection.
  • BPD is characterized by persistent pulmonary dysfunction and the need for ongoing treatment.

Purpose of the Study:

  • To review the current understanding of bronchopulmonary dysplasia pathogenesis.
  • To identify key areas for future research to improve BPD outcomes.
  • To emphasize the importance of translating research findings into clinical practice.

Main Methods:

  • Literature review of bronchopulmonary dysplasia research.
  • Analysis of pathogenetic pathways and contributing factors.
  • Synthesis of current therapeutic and preventive strategies.

Main Results:

  • Significant progress has been made in understanding and treating BPD.
  • Genetic predisposition, pathogenetic pathways, and clinical translation require further investigation.
  • Current knowledge has led to various therapies and preventive measures.

Conclusions:

  • Continued research is crucial to further reduce the incidence and severity of BPD.
  • Focusing on genetic factors, pathogenetic mechanisms, and clinical application will enhance patient care.
  • Translating research into effective clinical approaches remains a priority for managing BPD in premature infants.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...